A clinical trial to study the pain relief effect of two local anesthetic drugs ropivacaine and bupivacaine given to block the nerves located in abdominal wall after caesarean section.
Phase 4
- Conditions
- Health Condition 1: O82- Encounter for cesarean delivery without indication
- Registration Number
- CTRI/2018/10/015979
- Lead Sponsor
- Dr Aniket Kakade
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all patients who require caesarean delivery
Exclusion Criteria
Patient with ASA III or above
Any allergy to used drug
Local infection at the site of block
Patients requiring vertical abdominal incision and upper segment caesarean section
Patients requiring general anesthesia
Height of patient less than 150 cms and more than 180 cms (as these patients will require a different dosage of spinal anaesthesia)
Patients with thrombocytopenia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method